Related Experiment Videos
Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition
The American Journal of Physiology
|August 1, 1986
Summary
Dexamethasone treatment in newborn rats accelerates alveolar wall thinning by reducing fibroblast replication and altering cell composition. This steroid treatment impacts lung development, affecting cell types crucial for gas exchange.
Area of Science:
- Pulmonary biology
- Developmental biology
- Pharmacology
Background:
- Newborn rat lungs develop gas exchange saccules through septation between 4 and 14 days.
- Dexamethasone administration during this period is known to prevent septation.
Purpose of the Study:
- To investigate if dexamethasone accelerates alveolar wall thinning and alters lung wall composition in developing rats.
- To understand the cellular mechanisms behind dexamethasone's effects on lung development.
Main Methods:
- Daily administration of dexamethasone (0.1 micrograms) to newborn rats from day 4 to 13.
- Quantitative assessment of gas exchange wall thickness and cellular composition (type I and II cells, fibroblasts, endothelial cells, acellular matrix) at various time points.
Main Results:
- Dexamethasone treatment led to a 20% thinner gas exchange wall within 2 days.
- A significant reduction in the volume density of interstitial fibroblasts (35%) and an increase in type II cells (45%) were observed.
- At 14 days, volumes of type I cells, fibroblasts, and acellular matrix were reduced by approximately 35% in treated pups.
Conclusions:
- Dexamethasone accelerates alveolar wall thinning in developing rat lungs.
- The drug appears to reduce fibroblast replication more than type II cell division, impair type II to type I cell conversion, and not affect endothelial cell replication.